organovo future
Featured
Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over
In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,…
3D Printing News Briefs: October 13, 2017
It’s Friday the 13th – instead of walking under ladders, breaking mirrors, or generally going outside at all, it’s probably safest to stay in and read today’s edition of 3D…
Organovo Explains Why They’ve Raised an Additional $40M – Cites Potential for $400M in Annual Revenue
As we’ve mentioned in the past, the rollercoaster ride, known all too well to Organovo (NYSEMKT: ONVO) shareholders, has been quite bumpy. The stock price has dropped considerably following an announcement…
